Recursion Pharmaceuticals, Inc.
Stock Details
Is it expensive?
Trailing P/E Ratio
-2.31
Forward P/E Ratio
-3.95
PEG Ratio
0.04
-2.51
Price-to-Sales (TTM)
27.73
1.80
1.93
Market Cap
1.76B
1.26B
Is it profitable?
Net Profit Margin (TTM)
4.45%
Gross Profit Margin
-98.22%
Diluted EPS (TTM)
-1.16
-57.16%
66.41M
Is it growing?
-56.10%
-57.48%
Is it risky?
1.05
7.06
5.47
72.38M
Who owns it?
68.75%
2.27%
36.84%
530.63M
513.06M
Does it pay?
0.00%
0.00%
--
--
How much cash?
654.47M
-320.95M
-177.80M
1.24
- Price
- 3.32
- Percent Change
- -0.49 (12.76%)
- Previous Close
- 3.80
- Open
- 3.63
- Low
- 3.21
- High
- 3.70
52-Week Range Position (52WRP)
Cheap
Cheap
within its 1-year price range
$3.32
From 52W Low
+19.68%
From 52W High
-53.83%
Today
-12.76%
1Y Change
-38.27%
6M
$4.82
3M
$3.51
1M
$3.27
Today
$3.32
From 52W Low
+19.68%
From 52W High
-53.83%
Today
-12.76%
1Y Change
-38.27%
6M
$4.82
3M
$3.51
1M
$3.27
Today
$3.32
Cheap
within its 1-year price range
$3.32
Multi-Timeframe Analysis (MTA)
Reversal Signal
Short-term price is rising while the longer trend remains negative. In technical analysis this is called a reversal signal. The trend may be turning, but confirmation across more periods is needed before it becomes an uptrend. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
+1.4%
3M
-5.6%
6M
-31.2%
1Y
-38.3%
Rate of Change (ROC)
Decelerating
Price has reversed, now rising vs its usual downtrend. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- Recursion Pharmaceuticals, Inc.
- Founded
- 2013
- CEO
- Najat Khan
- Employees
- 600
- Fiscal Year End
- Dec 31, 2024
- Address
41 S Rio Grande Street
Salt Lake City
Utah
84101
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Biotechnology
- Website
- www.recursion.com
Indicators
Operating Cash Flow
-320.95M
Net Income
-559.78M
Mixed Signal
0.57
Cash flow is meaningfully below reported profit. Some gap is normal, but a persistent gap warrants questioning of the accounting.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Related Heatmaps
Cathie WoodPortfolio ARK Investment Management |
Indicators
Operating Cash Flow
-320.95M
Net Income
-559.78M
Mixed Signal
0.57
Cash flow is meaningfully below reported profit. Some gap is normal, but a persistent gap warrants questioning of the accounting.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Stock Details
Is it expensive?
Trailing P/E Ratio
-2.31
Forward P/E Ratio
-3.95
PEG Ratio
0.04
-2.51
Price-to-Sales (TTM)
27.73
1.80
1.93
Market Cap
1.76B
1.26B
Is it profitable?
Net Profit Margin (TTM)
4.45%
Gross Profit Margin
-98.22%
Diluted EPS (TTM)
-1.16
-57.16%
66.41M
Is it growing?
-56.10%
-57.48%
Is it risky?
1.05
7.06
5.47
72.38M
Who owns it?
68.75%
2.27%
36.84%
530.63M
513.06M
Does it pay?
0.00%
0.00%
--
--
How much cash?
654.47M
-320.95M
-177.80M
1.24
- Price
- 3.32
- Percent Change
- -0.49 (12.76%)
- Previous Close
- 3.80
- Open
- 3.63
- Low
- 3.21
- High
- 3.70
52-Week Range Position (52WRP)
Cheap
Cheap
within its 1-year price range
$3.32
From 52W Low
+19.68%
From 52W High
-53.83%
Today
-12.76%
1Y Change
-38.27%
6M
$4.82
3M
$3.51
1M
$3.27
Today
$3.32
From 52W Low
+19.68%
From 52W High
-53.83%
Today
-12.76%
1Y Change
-38.27%
6M
$4.82
3M
$3.51
1M
$3.27
Today
$3.32
Cheap
within its 1-year price range
$3.32
Multi-Timeframe Analysis (MTA)
Reversal Signal
Short-term price is rising while the longer trend remains negative. In technical analysis this is called a reversal signal. The trend may be turning, but confirmation across more periods is needed before it becomes an uptrend. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
+1.4%
3M
-5.6%
6M
-31.2%
1Y
-38.3%
Rate of Change (ROC)
Decelerating
Price has reversed, now rising vs its usual downtrend. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- Recursion Pharmaceuticals, Inc.
- Founded
- 2013
- CEO
- Najat Khan
- Employees
- 600
- Fiscal Year End
- Dec 31, 2024
- Address
41 S Rio Grande Street
Salt Lake City
Utah
84101
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Biotechnology
- Website
- www.recursion.com
Related Heatmaps
Cathie WoodPortfolio ARK Investment Management |